Radiogenomics and radiomics of skull base chordoma: Classification of novel radiomic subgroups and prediction of genetic signatures and clinical outcomes
Radiomics shows promise as a reliable, noninvasive tool for the prognostication and classification of SBCs, minimizing the need for invasive genetic testing and supporting personalized treatment strategies.
Authors
- Carl Henry Snyderman (ORCID: https://orcid.org/0000-0002-8920-4522)
- Priyadarshini Mamindla (ORCID: https://orcid.org/0000-0002-5070-1353)
- Nallammai Muthiah (ORCID: https://orcid.org/0000-0003-3170-1929)
- Vishal Peddagangireddy (ORCID: https://orcid.org/0000-0002-3912-2713)
- Georgios Andrea Zenonos (ORCID: https://orcid.org/0000-0001-9532-4160)
- Şerafettin Zenkin
- Hussein Abdallah (ORCID: https://orcid.org/0000-0003-3860-3598)
- Tritan Plute (ORCID: https://orcid.org/0000-0003-2065-6886)
- Zachary C. Gersey (ORCID: https://orcid.org/0000-0002-4353-0779)
- Murat Ak (ORCID: https://orcid.org/0000-0001-7384-478X)
- Rivka R. Colen (ORCID: https://orcid.org/0000-0002-0882-0607)
- Mohammadreza Amjadzadeh (ORCID: https://orcid.org/0000-0002-0877-9253)
- Eric W. Wang (ORCID: https://orcid.org/0000-0002-1180-5854)
- Paul A. Gardner (ORCID: https://orcid.org/0000-0002-1594-1722)
Institutions
- University of Miami (US)
- University of Pittsburgh (US)
- UPMC Health System (US)
- University of Miami Hospital (US)
- UPMC Hillman Cancer Center (US)
- University of Pittsburgh Medical Center (US)
- Neurological Surgery (US)
Publication Details
- Journal
- Neuro-Oncology
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1093/neuonc/noaf131
- Citations
- 3
- Primary Topic
- Bone Tumor Diagnosis and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.00